Nantahala Capital Management, LLC 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN |
Nantahala Capital Management, LLC | 2,834,336 9.990% |
36,748![]() (+1.31%) |
Filing |
2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Nantahala Capital Management, LLC | 1,952,368 5.100% |
1,952,368![]() (New Position) |
Filing |
2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Nantahala Capital Management, LLC | 2,797,588 9.900% |
2,797,588![]() (New Position) |
Filing |